Typhoid conjugate vaccines: is a single dose enough for durable protection?
Introduction Typhoid fever is widespread in developing countries. Most typhoid vaccines have gone into some disrepute for their substantial side effects and low efficacy. The latest typhoid vaccines use Salmonella‘s Vi-capsular polysaccharide (Vi-CPS) conjugated to a protein carrier. The WHO recomme...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Expert Review of Vaccines |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2476525 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|